Literature DB >> 29194979

Synthesis, adenosine receptor binding and molecular modelling studies of novel thieno[2,3-d]pyrimidine derivatives.

Pran Kishore Deb1,2, Raghuprasad Mailavaram3, Balakumar Chandrasekaran1, Venkata Rao Kaki1, Rajwinder Kaur1, Sonja Kachler4, Karl-Norbert Klotz4, Raghuram Rao Akkinepally5.   

Abstract

A series of new molecules containing a thieno[2,3-d]pyrimidine scaffold was synthesized and characterized by adopting an efficient synthetic scheme. The effect of a free or substituted amino group at 2-position as well as an oxo-group, imidazole or 1,2,4-triazole ring at 4-position of the scaffold on the affinity and selectivity towards adenosine receptors (ARs) was evaluated. Compounds 17-19 with a free amino group at 2-position along with the presence of an imidazole/1,2,4-triazole ring at 4-position of the scaffold showed selective binding affinities for hA2A AR, whereas carbamoylation of the amino group at 2-position (in the presence of an oxo-group at 4-position of the scaffold) increased the affinity and selectivity of certain compounds (7-10) for hA3 AR. Molecular dynamic simulation study of one of the most active compound 8 (Ki hA1  > 30 μm, hA2A  = 0.65 μm, and hA3  = 0.124 μm) revealed the role of important amino acid residues for imparting good affinity towards hA3 and hA2A ARs. Molecular docking studies were carried out for other compounds using the crystal structure of hA2A AR and a homology model of hA3 AR to rationalize their structure-activity relationships. The molecular docking results were in agreement with the experimental binding affinity data of ARs.
© 2017 John Wiley & Sons A/S.

Entities:  

Keywords:  adenosine receptors; binding; homology modelling; molecular docking; molecular dynamics; thieno[2,3-d]pyrimidine

Mesh:

Substances:

Year:  2017        PMID: 29194979     DOI: 10.1111/cbdd.13155

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  3 in total

1.  New fused pyrroles with rA1/A2A antagonistic activity as potential therapeutics for neurodegenerative disorders.

Authors:  Nadia Janse van Vuuren; Helena D Janse van Rensburg; Gisella Terre'Blanche; Lesetja J Legoabe
Journal:  Mol Divers       Date:  2021-11-05       Impact factor: 3.364

2.  Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives.

Authors:  Katharigatta N Venugopala; Nizar A Al-Shar'i; Lina A Dahabiyeh; Wafa Hourani; Pran Kishore Deb; Melendhran Pillay; Bashaer Abu-Irmaileh; Yasser Bustanji; Sandeep Chandrashekharappa; Christophe Tratrat; Mahesh Attimarad; Anroop B Nair; Nagaraja Sreeharsha; Pottathil Shinu; Michelyne Haroun; Mahmoud Kandeel; Abdulmalek Ahmed Balgoname; Rashmi Venugopala; Mohamed A Morsy
Journal:  Antibiotics (Basel)       Date:  2022-06-21

3.  Cytotoxicity and Antimycobacterial Properties of Pyrrolo[1,2-a]quinoline Derivatives: Molecular Target Identification and Molecular Docking Studies.

Authors:  Katharigatta N Venugopala; Vijayakumar Uppar; Sandeep Chandrashekharappa; Hassan H Abdallah; Melendhran Pillay; Pran Kishore Deb; Mohamed A Morsy; Bandar E Aldhubiab; Mahesh Attimarad; Anroop B Nair; Nagaraja Sreeharsha; Christophe Tratrat; Abdulmuttaleb Yousef Jaber; Rashmi Venugopala; Raghu Prasad Mailavaram; Bilal A Al-Jaidi; Mahmoud Kandeel; Michelyne Haroun; Basavaraj Padmashali
Journal:  Antibiotics (Basel)       Date:  2020-05-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.